Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma

Enfortumab vedotin is a novel antibody–drug conjugate targeting Nectin-4, which is highly expressed in urothelial carcinoma. However, the expression status of Nectin-4 in upper tract urothelial carcinoma (UTUC) remains unclear. The relationship between Nectin-4 and Programmed Death Ligand 1 (PD-L1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomiyama, Eisuke, Fujita, Kazutoshi, Rodriguez Pena, Maria Del Carmen, Taheri, Diana, Banno, Eri, Kato, Taigo, Hatano, Koji, Kawashima, Atsunari, Ujike, Takeshi, Uemura, Motohide, Takao, Tetsuya, Yamaguchi, Seiji, Fushimi, Hiroaki, Yoshimura, Kazuhiro, Uemura, Hirotsugu, Netto, George J., Nonomura, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432817/
https://www.ncbi.nlm.nih.gov/pubmed/32751328
http://dx.doi.org/10.3390/ijms21155390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432817/
https://www.ncbi.nlm.nih.gov/pubmed/32751328
http://dx.doi.org/10.3390/ijms21155390

Ejemplares similares